Results 211 to 220 of about 6,528 (248)

Megasin WSY10: A novel lantibiotic that inhibits methicillin-resistant Staphylococcus aureus (MRSA) in skim milk and preserves milk quality

Jiajia Ding, Mengyu Gao, Congcong Xu, Wen-Cheng Lv, Hualin Liu, Shu Liu, Deyin Zhao, Xin Zeng, Huawei Zeng, Bingyue Xin, Cuiying Du   +10 more
openalex   +1 more source

Antimicrobial Peptides: Mechanisms, Applications, and Therapeutic Potential. [PDF]

Infect Drug Resist
Alzain M, Daghistani H, Shamrani T, Almoghrabi Y, Daghistani Y, Alharbi OS, Sait AM, Mufrrih M, Alhazmi W, Alqarni MA, Saleh BH, Zubair MA, Juma NA, Niyazi HA, Niyazi HA, Halabi WS, Altalhi R, Kazmi I, Altayb HN, Ibrahem K, Alfadil A.   +20 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Lantibiotic Immunity

Current Protein & Peptide Science, 2008
Lantibiotics are a diverse family of bacterially synthesized antimicrobial peptides produced by gram-positive bacteria. They usually have a broad spectrum of targets, often including closely related strains. The production of lantibiotics must thus be coupled with a mechanism by which the producing strain can protect itself from the lethal action of ...
Lorraine A, Draper, R Paul, Ross, Colin, Hill, Paul D, Cotter   +3 more
openaire   +2 more sources

Immunity to lantibiotics

Antonie van Leeuwenhoek, 1996
Bacteria producing bacteriocins have to be protected from being killed by themselves. This mechanism of self-protection or immunity is especially important if the bacteriocin does not need a specific receptor for its action, as is the case for the type A lantibiotics forming pores in the cytoplasmic membrane.
P E, Saris, T, Immonen, M, Reis, H G, Sahl   +3 more
openaire   +2 more sources

Protein engineering of lantibiotics

Antonie van Leeuwenhoek, 1996
Whereas protein engineering of enzymes and structural proteins nowadays is an established research tool for studying structure-function relationships of polypeptides and for improving their properties, the engineering of posttranslationally modified peptides, such as the lantibiotics, is just coming of age.
Kuipers, O.P., Bierbaum, G., Ottenwälder, G., Dodd, H.M., Horn, N., Metzger, J., Kupke, T., Gnau, V., Bongers, R., van den Boogaard, P., Kosters, H., Rollema, H.S., de Vos, W.M., Siezen, R.J., Jung, G., Götz, F., Sahl, H.G., Gasson, M.J.   +17 more
openaire   +4 more sources

Antimicrobial mechanism of lantibiotics

Biochemical Society Transactions, 2012
Lantibiotics are ribosomally synthesized antimicrobial peptides that commonly target the cell wall precursor lipid II during their antimicrobial mechanism and exert their inhibitory activity by (i) inhibition of cell wall biosynthesis, and (ii) stable pore formation in the target membrane. Type-A(I) (i.e. nisin) and two-component (i.e.
Mohammad R, Islam, Jun-Ichi, Nagao, Takeshi, Zendo, Kenji, Sonomoto   +3 more
openaire   +2 more sources

Biomimetic Synthesis of Lantibiotics

Chemistry - A European Journal, 2000
The lantibiotics are a class of highly posttranslationally modified small peptide antibiotics containing numerous lanthionine and dehydroamino acid residues. We have prepared peptides containing multiple dehydroamino acids and cysteine residues in order to probe the biomimetic synthesis of the lantibiotics from their precursor peptides.
Burrage, S., Raynham, T., Williams, G., Essex, J. W., Allen, C., Cardno, M., Swali, V., Bradley, M.   +7 more
openaire   +2 more sources

Posttranslationally modified bacteriocins—the lantibiotics

Biopolymers, 2000
Lantibiotics are a subgroup of bacteriocins that are characterized by the presence of the unusual thioether amino acids lanthionine and 3-methyllanthionine generated through posttranslational modification. The biosynthesis of lantibiotics follows a defined pathway comprising modifications of the prepeptide, proteolytic activation, and export. The genes
A, Guder, I, Wiedemann, H G, Sahl
openaire   +2 more sources